We also showed that patients with HCC with MIM-B and caveolin-1 up-regulation experienced significantly worse outcomes and had lower survival rates than patients with HCC without MIM-B and caveolin-1 up-regulation. The gene discussed is CAV1; the disease is hepatocellular carcinoma.